For Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.
One year after his arrest, PixarBio CEO Francis Reynolds was convicted of defrauding investors of $12.7 million.
U.S. federal agents executed a warrant to search the Clio Laboratories in Georgia as part of a nationwide crackdown into genetic testing fraud against federal health insurance programs.
A federal grand jury recently filed criminal charges against several developers for fraud involving a Vermont biotech company.
U.S. authorities said 24 defendants were charged in connection with one of the largest healthcare fraud schemes prosecuted by the federal government, involving telemedicine companies and resulting in more than $1.2 billion of losses.
Report Shows Life Science Companies Continue to Be a Favorite Target of Securities Fraud Class Action Lawsuits
Despite a decline over the past year of class action lawsuits, life science companies remain a popular target for securities fraud litigation.
Walgreens Boots Alliance Inc. will pay $269.2 million to settle two whistleblower lawsuits accusing the pharmacy chain of civil fraud for overbilling federal healthcare programs for over a decade.
Here is a look at BioSpace’s top 10 stories of 2018.
A hospital operator owned by Community Health Systems will pay more than $260 million to resolve claims that Health Management Associates defrauded government healthcare programs and paid doctors kickbacks for patient referrals, the U.S. Justice Department said.